Os desafios no manejo da insulinoterapia em pacientes diabetes tipo 1: uma revisão integrativa

Abstract

Introduction: Type 1 diabetes mellitus (T1DM) is an autoimmune condition characterized by the destruction of pancreatic beta cells, leading to absolute insulin deficiency. Consequently, individuals with T1DM require lifelong insulin therapy. Despite advances in diabetes management, living with T1DM remains a significant challenge, demanding strict adherence to complex treatment regimens. Objectives: This review aims to identify the primary obstacles encountered in managing insulin therapy among individuals with T1DM. Methodology: A comprehensive literature review was conducted using the MEDLINE and LILACS databases, focusing on articles published within the past five years. The search terms included "Diabetes Mellitus, Type 1", "Medication Adherence", "Insulin", and "Treatment Adherence and Compliance". Results: The analysis of six articles revealed that managing insulin therapy in T1DM is multifaceted and influenced by a myriad of factors, including socioeconomic conditions, psychological factors, clinical variables, and access to healthcare. Conclusion: Barriers to effective glycemic control in individuals with T1DM include limited access to advanced technologies, challenges in adhering to complex treatment regimens, and inadequate social support. To address these challenges, future research should focus on developing innovative, multidisciplinary approaches to improve glycemic control and quality of life for individuals with T1DM.